Press release
Influenza Medications Market Expected to Hit USD 1,386.21 million by 2032, Demonstrating Strong 4.3% Expansion | PMR
Influenza Medications Market
Influenza, commonly referred to as flu, is a viral infection that affects the throat, nose, and lungs. The symptoms of flu usually come on suddenly and take the form of cough, sore throat, fever, runny nose, headaches, and fatigue. Flu typically causes mild illness, but negligence can lead to severe illness or even death.
๐๐ฅ๐ข๐๐ค ๐ญ๐จ ๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ง๐ ๐๐ซ๐ข๐ฏ๐ ๐๐ฆ๐ฉ๐๐๐ญ๐๐ฎ๐ฅ ๐๐๐๐ข๐ฌ๐ข๐จ๐ง๐ฌ:
https://www.polarismarketresearch.com/industry-analysis/influenza-medications-market/request-for-sample
The symptoms of influenza can be managed by taking ample rest and consuming plenty of fluids. But in case of a more severe infection, healthcare professionals may prescribe an antiviral medicine for treating the flu. These medications can take the form of oseltamivir, baloxavir, and zanamivir. Baloxavir and oseltamivir are intended for oral consumption, whereas zanamivir is inhaled using a device similar to an asthma inhaler.
๐๐จ๐ฆ๐ ๐๐ ๐๐ก๐ ๐๐จ๐ฉ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐๐ฉ๐๐ซ๐๐ญ๐ข๐ง๐ ๐๐ง ๐๐ก๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐:
โข AbbVie (US)
โข AstraZeneca (UK)
โข Bayer AG (Germany)
โข Bharat Biotech (India)
โข BioCryst Pharmaceuticals (US)
โข Daiichi Sankyo (Japan)
โข Mylan (US)
โข Novartis AG (Switzerland)
โข Roche Diagnostics (Switzerland)
โข Sanofi SA (France)
โข Seqirus (Australia)
๐๐๐ญ ๐๐ก๐๐๐ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/3761/2
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ฏ๐๐ซ๐ฏ๐ข๐๐ฐ
๐๐ง๐๐ฅ๐ฎ๐๐ง๐ณ๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ, ๐๐ง๐๐ฅ๐ฎ๐๐ง๐ณ๐ ๐๐ฒ๐ฉ๐ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ฏ๐๐ง๐ฎ๐ - ๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐๐๐ - ๐๐๐๐)
โข Influenza A
โข Influenza B
๐๐ง๐๐ฅ๐ฎ๐๐ง๐ณ๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ, ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ฏ๐๐ง๐ฎ๐ - ๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐๐๐ - ๐๐๐๐)
โข Baloxavir Marboxil
โข Oseltamivir Phosphate
โข Others
๐๐ง๐๐ฅ๐ฎ๐๐ง๐ณ๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ, ๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ ๐๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐๐๐ฏ๐๐ง๐ฎ๐ - ๐๐๐ ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐๐๐๐ - ๐๐๐๐)
โข Hospital Pharmacies
โข Retail Pharmacies
โข Online Pharmacies
โข Others
๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ:
๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐จ๐ ๐๐ง๐๐ฅ๐ฎ๐๐ง๐ณ๐:Influenza medications are used for the treatment of symptomatic influenza infections to reduce the severity and duration of symptoms and prevent complications.
๐๐ซ๐จ๐ฉ๐ก๐ฒ๐ฅ๐๐ฑ๐ข๐ฌ: Certain antiviral medications are prescribed for prophylactic use in individuals who are at high risk of developing severe complications from influenza, such as healthcare workers and individuals with compromised immune systems.
๐๐๐ง๐๐๐ฆ๐ข๐ ๐๐ซ๐๐ฉ๐๐ซ๐๐๐ง๐๐ฌ๐ฌ: Influenza medications play a crucial role in pandemic preparedness efforts, including stockpiling antiviral drugs and developing vaccines to mitigate the impact of potential influenza pandemics.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐ฆ๐จ๐ซ๐ ๐๐๐ญ๐๐ข๐ฅ๐ฌ: https://www.polarismarketresearch.com/industry-analysis/influenza-medications-market
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ
โข The influenza medications market segmentation is primarily based on influenza type, treatment, distribution channel, and region.
โข By influenza type insights, the influenza A segment accounted for the largest market share owing to the rising number of cases of this influenza type.
โข By treatment insights, the oseltamivir segment held the maximum revenue share due to its widespread adoption as a prescribed drug.
๐๐ง๐๐ฅ๐ฎ๐๐ง๐ณ๐ ๐๐๐๐ข๐๐๐ญ๐ข๐จ๐ง๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โข Influenza A segment accounted for notable share, owing to rising incidences and awareness regarding the importance of proper medications
โข Oseltamivir phosphate segment held the majority share, that is attributed to its advantages including higher efficiency and effectiveness against several strains
โข Online pharmacies segment will grow at highest pace, emergence of online pharmacy platforms offering several benefits to patients like convenience and easy accessibility
โข North America dominated the market, on account of prevalence of influenza and rising investments in R&D activities to develop new formulations
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
๐๐๐ฆ๐จ๐ฌ๐ญ๐๐ฌ๐ข๐ฌ ๐๐ง๐ ๐๐ข๐ฌ๐ฌ๐ฎ๐ ๐๐๐๐ฅ๐ข๐ง๐ ๐๐ ๐๐ง๐ญ๐ฌ ๐๐๐ซ๐ค๐๐ญ: https://www.polarismarketresearch.com/industry-analysis/hemostasis-tissue-sealing-agents-market
๐๐จ๐ฎ๐ญ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ: https://www.polarismarketresearch.com/industry-analysis/gout-therapeutics-market
๐๐จ๐๐ญ ๐๐ข๐ฌ๐ฌ๐ฎ๐ ๐๐๐ซ๐๐จ๐ฆ๐ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ: https://www.polarismarketresearch.com/industry-analysis/soft-tissue-sarcoma-treatment-market
๐๐ญ๐๐ฆ ๐๐๐ฅ๐ฅ ๐๐ก๐๐ซ๐๐ฉ๐ฒ ๐๐๐ซ๐ค๐๐ญ: https://www.polarismarketresearch.com/industry-analysis/stem-cell-therapy-market
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Influenza Medications Market Expected to Hit USD 1,386.21 million by 2032, Demonstrating Strong 4.3% Expansion | PMR here
News-ID: 3461667 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for Influenza
Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies โฆ
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.โฆ
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza โฆ
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780
This latest report researches the industry structure, sales, revenue,โฆ
Influenza Medication Market - Fight off the influenza virus with effective and r โฆ
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859
This latest report researches the industry structure, sales, revenue,โฆ
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced โฆ
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, whichโฆ
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating โฆ
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, whichโฆ
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del โฆ
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,โฆ
